Sars, Cov-II Influenza A influenza B Nucleic Acidum combined
Product Name
HWTS, RT060A-Sars-Cov-II Influenza A Influenza B Nucleic Acidum combined dependenda Kit (Fluorence PCR)
Certificatorium
AKL / TGA / CE
Epidemiology
Corona Virus Morbus MMXIX (CoviD-XIX) est causa per Sars-Cov- II, quod pertinet ad β coronavirus de genere. Covi-XIX est acutus respiratorii infectious morbus et turba plerumque susceptibilis. In praesens, in Sars-Cov-II inficiuntur aegris sunt principalis fons infectio, et asymptomatic aegros potest etiam facti fons infectio. Ex in hodiernae epidemiological inquisitionis, in incubitu tempus est 1-14 dies, plerumque 3-7 diebus. Pelagus manifestationes febricitantem, arida tussis et lassitudine. A paucis aegris ut symptoms ut nasi obstructio, liquescit naribus, faucium, Myalgia et fluxus.
Influenza est acutus respiratoria infectio per influenza virus. Est altus infectious et diffundit maxime per tussis et sternumentum. Solet erumpit in fonte et hiems. Sunt tria genera influenza, influenza a (ifv a), influenza B (ifv b) et influenza C (ifv c), tam ex illis quae ad OrtomyXovirus familia. Influenza A et B, qui sunt unius, segny RNA virus, sunt principalis causas humani morborum. Influenza A est acutus respiratorii infectious morbus, inter H1N1, H3N2 et alia subtypes, est facile ad mutationem. In global tumultu, "subcinctus" refertur ad mutationem de influenza a, unde in novam virales "subtype". Influenza B dividitur in duas linagages: Yamagata et Victoria. Influenza B habent solum antigenic egisse, et evadere custodia et eliminanda humana immune ratio per mutationem. Sed influenza B Viruses evolve tardius quam humana influenza a, quae etiam causa respiratorii infectiones et epidemics in hominibus.
Channel
Fam | SARS-CoV-2 |
ROX | Ifv b |
CYV | Ifv est |
Vic (Hex) | Internum imperium genes |
Technical parametri
Repono | Liquid: ≤, XVIII ℃ in tenebris |
Lyophilization: ≤30 ℃ in tenebris | |
PLUTEUM-vitae | Liquid: IX mensibus |
Lyophilization: XII mensibus | |
Specimen Type | Nasopharyngeal Swabs, Oropharyngeal Swabs |
Ct | ≤38 |
CV | ≤5.0% |
LOD | CCC copies / ml |
Specifica | Crucis test eventus ostendit quod ornamentum est compatible cum humana coronavirus Sarsr- Cov, Mersr-Cov, HCOV-OC43, HCOV-229E, HCOV-Hc43, HCOV-NL63, HCOV-HCV, HCOV, NL63, Viris I, II III, Rhinovirusa, B et C, adenovirus I, II, III, IV, V, VII et LV, Metapneumovirus VII, B, C et D, Humanum Cytoplasmic pulmonalis virus, EB virus, virus humana Cytomegalovirus, Rotavirus, Norovirus, Mycoplasma, Mycoplasma, Chlamydia, Mycoplasma Pneumoniae, Chlamydia Pneumoniae, Legionella, Pertussis, Haemophilus influenzae, Staphylococcus Aureus, Streptococcus Pseumoniae, Streptococcus pyogenes, Klebsiella Pneumoniae, Mycobacterium, Aspergillus Fumigatus, Candida Albicans, Candida Yersini et crucem reactionem inter Pneumocystis Yersini CryptoCococcus Neoformans. |
Applicabiles instrumenta: | Potest aequare amet fluorescent PCR instrumenta in foro. Applicari Biosystems (VII) D Real-vicis PCR Systems Applicari Biosystems (VII) D ieiunium realis-vicis PCR systems QuantStudio®5 Real-vicis PCR Systems Slan-96P realis-vicis PCR systems LightcyCler®®®® Real-vicis PCR ratio Linenene (IX) DC plus realis-vicis PCR deprehensio ratio MA-(VI) Real-vicis quantitatis scelerisque cycler BIOD CFX96 Real-vicis PCR ratio BIOD CFX Opus XCVI Real-vicis PCR ratio |
ADMODO
Optio I.
Commendatur extraction Reagent: Macro & Micro-test viral DNA / RNA Kit (HWTS-MMMCI, HWTS-3004-32, HWTS-3004-48) et Macro-Test Automatic Nucleiic Acidum extractor (HWTS-MMMVI).
Optio II.
Commendatur extraction Reagent: nucleic acidum extractionem et purificationem Reagent (ydp302) by Tiangen Biotech (Beijing) Co., Ltd.